Influence of nutritional supplements on antibody levels in pregnant women vaccinated with inactivated SARS-CoV-2 vaccines.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2024
2024
Historique:
received:
14
07
2023
accepted:
03
09
2023
medline:
11
3
2024
pubmed:
7
3
2024
entrez:
7
3
2024
Statut:
epublish
Résumé
Because of the significantly higher demand for nutrients during pregnancy, pregnant women are more likely to have nutrient deficiencies, which may adversely affect maternal and fetal health. The influence of nutritional supplements on the immune effects of inactivated SARS-CoV-2 vaccines during pregnancy is not clear. In a multicenter cross-sectional study, we enrolled 873 pregnant women aged 18-45 y in Guangdong, China. The general demographic characteristics of pregnant women and their use of nutritional supplements were investigated, and the serum antibody levels induced by inactivated SARS-CoV-2 vaccines were measured. A logistic regression model was used to analyze the association between nutritional supplements and SARS-CoV-2 antibody levels. Of the 873 pregnant women enrolled, 825 (94.5%) took folic acid during pregnancy, 165 (18.9%) took iron supplements, and 197 (22.6%) took DHA. All pregnant women received at least one dose of inactivated SARS-CoV-2 vaccine, and the positive rates of serum SARS-CoV-2 neutralizing antibodies (NAbs) and immunoglobulin G (IgG) antibodies were 44.7% and 46.4%, respectively. After adjustment for confounding factors, whether pregnant women took folic acid, iron supplements, or DHA did not influence NAb positivity or IgG positivity (P > 0.05). Compared with pregnant women who did not take folic acid, the odds ratios (ORs) for the presence of SARS-CoV-2 NAb and IgG antibody in pregnant women who took folic acid were 0.67 (P = 0.255; 95% CI, 0.34-1.32) and 1.24 (P = 0.547; 95% CI, 0.60-2.55), respectively. Compared with pregnant women who did not take iron supplements, the ORs for the presence of NAb and IgG antibody in pregnant women who took iron supplements were 1.16(P = 0.465; 95% CI, 0.77-1.76) and 0.98 (P = 0.931; 95% CI, 0.64-1.49), respectively. Similarly, the ORs for NAb and IgG antibody were 0.71 (P = 0.085; 95% CI, 0.49-1.04) and 0.95 (P = 0.801; 95% CI, 0.65-1.38) in pregnant women who took DHA compared with those who did not. Nutritional supplementation with folic acid, iron, or DHA during pregnancy was not associated with antibody levels in pregnant women who received inactivated SARS-CoV-2 vaccines.
Sections du résumé
BACKGROUND
BACKGROUND
Because of the significantly higher demand for nutrients during pregnancy, pregnant women are more likely to have nutrient deficiencies, which may adversely affect maternal and fetal health. The influence of nutritional supplements on the immune effects of inactivated SARS-CoV-2 vaccines during pregnancy is not clear.
METHODS
METHODS
In a multicenter cross-sectional study, we enrolled 873 pregnant women aged 18-45 y in Guangdong, China. The general demographic characteristics of pregnant women and their use of nutritional supplements were investigated, and the serum antibody levels induced by inactivated SARS-CoV-2 vaccines were measured. A logistic regression model was used to analyze the association between nutritional supplements and SARS-CoV-2 antibody levels.
RESULTS
RESULTS
Of the 873 pregnant women enrolled, 825 (94.5%) took folic acid during pregnancy, 165 (18.9%) took iron supplements, and 197 (22.6%) took DHA. All pregnant women received at least one dose of inactivated SARS-CoV-2 vaccine, and the positive rates of serum SARS-CoV-2 neutralizing antibodies (NAbs) and immunoglobulin G (IgG) antibodies were 44.7% and 46.4%, respectively. After adjustment for confounding factors, whether pregnant women took folic acid, iron supplements, or DHA did not influence NAb positivity or IgG positivity (P > 0.05). Compared with pregnant women who did not take folic acid, the odds ratios (ORs) for the presence of SARS-CoV-2 NAb and IgG antibody in pregnant women who took folic acid were 0.67 (P = 0.255; 95% CI, 0.34-1.32) and 1.24 (P = 0.547; 95% CI, 0.60-2.55), respectively. Compared with pregnant women who did not take iron supplements, the ORs for the presence of NAb and IgG antibody in pregnant women who took iron supplements were 1.16(P = 0.465; 95% CI, 0.77-1.76) and 0.98 (P = 0.931; 95% CI, 0.64-1.49), respectively. Similarly, the ORs for NAb and IgG antibody were 0.71 (P = 0.085; 95% CI, 0.49-1.04) and 0.95 (P = 0.801; 95% CI, 0.65-1.38) in pregnant women who took DHA compared with those who did not.
CONCLUSIONS
CONCLUSIONS
Nutritional supplementation with folic acid, iron, or DHA during pregnancy was not associated with antibody levels in pregnant women who received inactivated SARS-CoV-2 vaccines.
Identifiants
pubmed: 38452000
doi: 10.1371/journal.pone.0289255
pii: PONE-D-23-21116
pmc: PMC10919710
doi:
Substances chimiques
Antibodies, Neutralizing
0
Antibodies, Viral
0
COVID-19 Vaccines
0
Folic Acid
935E97BOY8
Immunoglobulin G
0
Iron
E1UOL152H7
Vaccines, Inactivated
0
Types de publication
Multicenter Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0289255Informations de copyright
Copyright: © 2024 Zhang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Am J Clin Nutr. 2016 Feb;103(2):495-504
pubmed: 26739036
Nutrients. 2016 Nov 02;8(11):
pubmed: 27827838
Exp Ther Med. 2020 Sep;20(3):2439-2443
pubmed: 32765730
Pediatr Res. 2016 Jun;79(6):922-8
pubmed: 26866907
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
BMC Pregnancy Childbirth. 2022 Jan 14;22(1):33
pubmed: 35030996
J Am Acad Dermatol. 2021 Nov;85(5):1274-1284
pubmed: 34363909
Pediatr Res. 2016 Nov;80(5):656-662
pubmed: 27362506
JAMA Pediatr. 2021 Aug 1;175(8):817-826
pubmed: 33885740
Clin Nutr. 2016 Jun;35(3):741-7
pubmed: 26070630
Nutr Rev. 2020 Oct 1;78(10):813-826
pubmed: 31925443
Nutrients. 2018 Oct 17;10(10):
pubmed: 30336639
Front Immunol. 2020 Jul 13;11:1313
pubmed: 32754150
Am J Obstet Gynecol. 2018 Apr;218(4):379-389
pubmed: 28844822
Nat Rev Immunol. 2021 Oct;21(10):626-636
pubmed: 34373623
J Nutr. 2019 Apr 1;149(4):628-634
pubmed: 30418579
Am J Clin Nutr. 2007 Jun;85(6):1572-7
pubmed: 17556695
Nutrients. 2020 Sep 29;12(10):
pubmed: 33003648
Nutrients. 2021 Feb 21;13(2):
pubmed: 33670026
Inflammopharmacology. 2021 Aug;29(4):1001-1016
pubmed: 34110533
Drug Saf. 2021 Dec;44(12):1247-1269
pubmed: 34739716
JAMA. 2021 Aug 24;326(8):728-735
pubmed: 34251417
J Affect Disord. 2022 Apr 1;302:258-272
pubmed: 35066009
Br J Nutr. 2012 Jun;107 Suppl 2:S77-84
pubmed: 22591905
Curr Opin Chem Biol. 2010 Apr;14(2):218-24
pubmed: 20015678
PLoS Med. 2021 Aug 10;18(8):e1003720
pubmed: 34375336
J Nutr. 2018 Mar 1;148(3):409-418
pubmed: 29546296
Eur Respir J. 2020 May 14;55(5):
pubmed: 32217650
Obstet Gynecol. 2014 Dec;124(6):1080-1087
pubmed: 25415158
Hum Vaccin Immunother. 2018;14(10):2478-2484
pubmed: 29923793
Paediatr Perinat Epidemiol. 2018 Jul;32(4):346-357
pubmed: 29882975
Nutrients. 2020 May 27;12(6):
pubmed: 32471251
Nutrients. 2022 Feb 16;14(4):
pubmed: 35215486
Nutrients. 2018 May 12;10(5):
pubmed: 29757207
BMJ. 2013 Jun 21;346:f3443
pubmed: 23794316